Thanks Ressy. Very interesting. The announcement implies the...

Thanks Ressy. Very interesting. The announcement implies the manufacture of the drug batch for the trial was already completed at that time (26-5-2021). I can’t imagine this was done without payment as the trial was not approved by the EMA at that time. Has the drug for trial already been paid for before the CR in November? This would mean at least $7.4 million of the CR not required?

Although that would make the Use of Funds in the CR incorrect (you wouldn’t need to use those funds if they were already paid for)